Utkan Boran Aşik

Utkan Boran Aşik

Auto-generated profile, based on publicly available information

Utkan Boran Aşik

Department of Psychiatry, Faculty of Medicine, Lokman Hekim University, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2026 in Child and Adolescent Psychiatry and Mental Health
Verified
Journal Article
Open access
SDSamet Can Demirci
Samet Can Demirci
AÖAhmet Özaslan
Ahmet Özaslan
BMBurak Erman Menkü
Burak Erman Menkü
UAUtkan Boran Aşik
Utkan Boran Aşik
ÇYÇağatay Haşim Yurtseven
Çağatay Haşim Yurtseven
ZAZehra Arikan
Zehra Arikan

13 June 2026 in BMC Psychiatry
Verified
Journal Article
Open access
SDSamet Can Demirci
Samet Can Demirci
UAUtkan Boran Aşik
Utkan Boran Aşik
BMBurak Erman Menkü
Burak Erman Menkü
ÇYÇağatay Haşim Yurtseven
Çağatay Haşim Yurtseven
NANaz Aksoy
Naz Aksoy
ZAZehra Arikan
Zehra Arikan
Symptoms of attention-deficit/hyperactivity disorder (ADHD) are commonly observed in individuals with substance use disorders (SUD) and may be associated with increased addiction severity. Time perspective is a potential psychological mechanism that could explain the association between retrospectively reported childhood ADHD symptoms and addiction severity. In this study, we examined whether the five dimensions of the Zimbardo Time Perspective Inventory (ZTPI) statistically accounted for cross-sectional indirect associations between retrospectively reported childhood ADHD symptoms and addiction severity. This cross-sectional study included 226 inpatients aged 18-25 years with SUD. retrospectively reported childhood ADHD symptoms was assessed using the Wender Utah Rating Scale (WURS), adult ADHD symptoms using the ASRS, time perspective using the ZTPI, general psychological distress using the DASS-21, and addiction severity using the Addiction Profile Index (API). Group comparisons were analyzed using the Kruskal-Wallis test with Bonferroni-corrected pairwise comparisons, while interrelationships between variables were examined using Spearman's rank correlation. A parallel indirect-effect model was estimated to examine whether ZTPI dimensions statistically accounted for the association between WURS and API, controlling for age, gender, and DASS-21 total scores. The stimulant-predominant group showed higher WURS, ASRS, and Present Hedonistic scores than both the cannabis and pregabalin/gabapentin groups. It also showed higher API scores and lower Future scores than the cannabis group. Higher WURS scores were significantly associated with an earlier onset of substance use, as well as higher ASRS, Past-Negative, Present-Hedonistic, Present-Fatalistic, and API scores; and lower Future scores. In the cross-sectional indirect-effect model, WURS was significantly associated with all five ZTPI subscales. In the final model, the Past-Negative, Present-Hedonistic, Present-Fatalistic, and Future subscales were significantly associated with API scores, whereas the Past-Positive subscale was not significant. The total and direct associations of WURS with API remained significant, and the total indirect effect was also significant. The model explained 58.8% of the variance in addiction severity. In this cross-sectional inpatient sample, retrospectively reported childhood ADHD symptoms were associated with addiction severity, and this association was statistically accounted for in part by specific time perspective dimensions, particularly higher Present Hedonistic and lower Future orientation. These findings should be interpreted as cross-sectional indirect associations rather than evidence of temporal or causal mediation. If supported by longitudinal studies, time-perspective-informed interventions may represent clinically relevant targets in ADHD-SUD comorbidity. Not applicable. Not applicable.

23 June 2026 in ADDICTA: The Turkish Journal on Addictions
Verified
Journal Article
Open access
SDSamet Can Demirci
Samet Can Demirci
BMBurak Erman Menkü
Burak Erman Menkü
UAUtkan Boran Aşık
Utkan Boran Aşık
NANaz Aksoy
Naz Aksoy
ZÖZeynep Sıla Öztürk
Zeynep Sıla Öztürk
ZAZehra Arıkan
Zehra Arıkan
Stigmatizing attitudes held by healthcare professionals toward individuals with alcohol and substance use disorders (ASUD) can hinder access to care and negatively affect treatment outcomes. Clinical experience may play a key role in shaping these attitudes. This cross-sectional study included 230 healthcare professionals, 96 of whom had experience in addiction treatment centers and 134 who worked in general medical settings. Participants completed three validated instruments: the Alcohol Use Disorder Stigma Scale, the Substance Use Disorder Stigma Scale, and the Attitudes Toward Individuals Using Addictive Substances Scale. Independent samples t-tests were conducted to assess group differences. Professionals with addiction treatment experience exhibited significantly lower levels of stigma and negative attitudes. Alcohol-related stigma scores were 52.40 (SD = 17.71) for experienced professionals and 74.21 (SD = 19.06) for those without experience (t(228) = -8.81, p < .001). For substance-related stigma, the scores were 74.33 (SD = 24.25) vs. 97.05 (SD = 18.76) (t(228) = -8.01, p < .001). Negative attitude scores toward addictive substance users were also lower in the experienced group: 77.38 (SD = 20.42) vs. 97.05 (SD = 21.06) (t(228) = -7.07, p < .001). Direct clinical experience with individuals affected by ASUD is associated with reduced stigma among healthcare professionals. Integrating supervised clinical exposure into healthcare education may be an effective strategy to reduce stigma and improve the quality of addiction care.